InsiderClue
← All stocks

Beam Therapeutics Inc.

BEAM Net selling
CIK 0001745999 #1765 in the set updated 18 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$19.80M
$3.09M on a plan · $6.67M straight out of an exercise
Sold at will
$10.05M
3 of 33 sales
Net
−$19.80M
−$10.05M against sales at will

By person

7 insiders · 35 transactions
35.7×

John Evans holds 35.7 times base salary in stock. $26.96M of shares against $755.00K in salary for 2025.

Salary from the company's own proxy. The shares are what John Evans last reported holding, valued at $25.74, the price Common Stock was last bought or sold at on the open market here, on 27 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
FMR LLC entity
10% owner
—
$10.05M (3)
−$10.05M
854,583
0.8274%
$22.00M
−64.7%
Evans John M.
CEO
—
$6.28M (13) scheduled
−$6.28M
1,047,205
1.01%
$26.96M
+1.6%
Ciaramella Giuseppe
President
—
$1.41M (2) scheduled
−$1.41M
253,911
0.2458%
$6.54M
+49.7%
Bellon Christine
Chief Legal Officer
—
$880.98K (7) scheduled
−$880.98K
109,711
0.1062%
$2.82M
+4.9%
Simon Amy
Chief Medical Officer
—
$606.68K (3) scheduled
−$606.68K
85,696
0.0830%
$2.21M
+23.3%
Cavanagh Bethany J
SVP, Finance and Treasurer
—
$399.46K (4) scheduled
−$399.46K
51,171
0.0495%
$1.32M
+20.9%
Emany Sravan Kumar
Chief Financial Officer
—
$170.57K (1) scheduled
−$170.57K
105,456
0.1021%
$2.71M
—

Individual transactions

2
Insider
Date
Role
Action
Shares
Price
Amount
Ciaramella Giuseppe
17 Jun 2026
President
Exercised, kept
29,000
$1.03
$29.87K
Ciaramella Giuseppe
17 Jun 2026
President
Exercised, kept
6,505
$0.67
$4.36K
Show all 35 transactions →

What was left out

Form 4 filings counted 41
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 13
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 1,748,939
History held since 11 Feb 2020